Stapled Peptides as Inhibitors of mRNA Deadenylation
Open Access
- 6 November 2024
- journal article
- research article
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 64 (1) , e202413911
Abstract
Therapeutic intervention targeting mRNA typically aims at reducing the levels of disease‐causing sequences. Achieving the opposite effect of blocking the destruction of beneficial mRNA remains underexplored. The degradation of mRNA starts with the removal of poly(A) tails, reducing their stability and translational activity, which is mainly regulated by the CCR4‐NOT complex. The subunit NOT9 binds various RNA binding proteins, that recruit mRNA in a sequence‐specific manner to the CCR4‐NOT complex to promote their deadenylation. These RNA binding proteins interact with NOT9 through a helical NOT9 binding motif, which we used as a starting point for development of the hydrocarbon stapled peptide NIP‐2. The peptide (KD=60.4 nM) was able to inhibit RNA‐binding (IC50=333 nM) as well as the deadenylation activity of the CCR4‐NOT complex in vitro while being cell‐permeable (cell‐permeability EC50=2.44 μM). A co‐crystal structure of NIP‐2 bound to NOT9 allowed further optimization of the peptide through point mutation leading to NIP‐2‐H27A‐N3 (KD=122 nM) with high cell permeability (cell‐permeability EC50=0.34 μM). The optimized peptide was able to inhibit deadenylation of target mRNAs when used in HeLa cells at a concentration of 100 μM, demonstrating the feasibility of increasing mRNA stability.Keywords
Funding Information
- H2020 Marie Skłodowska-Curie Actions (101061526)
This publication has 66 references indexed in Scilit:
- Thermal proteome profiling identifies the membrane-bound purinergic receptor P2X4 as a target of the autophagy inhibitor indophagolinCell Chemical Biology, 2021
- The Challenge of Peptide Proteolytic Stability Studies: Scarce Data, Difficult Readability, and the Need for HarmonizationAngewandte Chemie International Edition, 2020
- 1‐Hydroxy‐xanthine derivatives inhibit the human Caf1 nuclease and Caf1‐containing nuclease complexes via Mg2+‐dependent bindingFEBS Open Bio, 2019
- RNA Degradation in Neurodegenerative Disease2018
- Structural basis for inhibition of the deadenylase activity of human CNOT6LFEBS Letters, 2016
- Discovery, synthesis and biochemical profiling of purine-2,6-dione derivatives as inhibitors of the human poly(A)-selective ribonuclease Caf1Bioorganic & Medicinal Chemistry Letters, 2015
- Chemical Synthesis of Hydrocarbon‐Stapled Peptides for Protein Interaction Research and Therapeutic TargetingCurrent Protocols in Chemical Biology, 2011
- Control of poly(A) tail lengthWIREs RNA, 2010
- The structural basis for deadenylation by the CCR4-NOT complexProtein & Cell, 2010
- Synthesis of Bicyclic Alkene‐/Alkane‐Bridged Nisin Mimics by Ring‐Closing Metathesis and their Biochemical Evaluation as Lipid II Binders: toward the Design of Potential Novel AntibioticsChemBioChem, 2007